Vanguard Intermediate-Term Bond ETF
Limited financial coverage for BIV.
Not enough data to compute a meaningful composite — typical for foreign-listed ADRs, recent IPOs, or thinly-covered small caps. Live quote, chart, and any available stats still render below.
About the company
Vanguard Bond Index Funds - Vanguard Intermediate-Term Bond ETF is an exchange traded fund launched and managed by The Vanguard Group, Inc. The fund invests in the fixed income markets of the United States. It invests in investment-grade debt securities including government, corporate, and international dollar-denominated bonds with maturities between 5 and 10 years that are rated BBB- or above by S&P.
- IPO
- 2007
- HQ
- Malvern, PA, US
Price Chart
- Market Cap
- $52.27B
- Div Yield
- 4.24%
- 52W High
- $79.09
- 52W Low
- $75.63
- 50D MA
- $76.61
- 200D MA
- $77.63
- Beta
- 1.03
- Avg Volume
- 1.60M
Get TickerSpark's AI analysis on BIV
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Dec 13, 04 | PERSEUS SOROS BIOPHARMACEUTICAL FUND LP | other | 750,000 |
| Dec 13, 04 | PERSEUS SOROS BIOPHARMACEUTICAL FUND LP | other | 1,500,000 |
| Dec 13, 04 | PERSEUS SOROS BIOPHARMACEUTICAL FUND LP | other | 1,500,000 |
| Jun 21, 06 | Dunker Kristen Marie | other | 55,000 |
| May 13, 04 | PERSEUS SOROS BIOPHARMACEUTICAL FUND LP | buy | 375,044 |
| May 13, 04 | PERSEUS SOROS BIOPHARMACEUTICAL FUND LP | buy | 75,009 |
Our BIV coverage
Recent articles, reports, and earnings notes.
No research on BIV yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate BIV report →Similar companies
Peers in the same neighborhood.